| HOME >> BIOLOGY >> TECHNOLOGY |
Gross profit $7,738 $7,807
Gross margin % of service revenue 38.2% 43.3%
Total service revenue $245,336 $191,215
Total gross profit $84,073 $66,927
Gross margin % of service revenue 34.3% 35.0%
Revenue by Geography
The Americas $99,735 $76,682
Europe, Middle East & Africa 129,105 104,025
Asia/Pacific 16,496 10,508
Total service revenue $245,336 $191,215
Quarterly Supplemental Financial Data
Total revenue $294,723 $240,619
Investigator fees 38,496 29,214
Gross revenue $333,219 $269,833
DSO 59 43
Capital expenditures $18,794 $9,530
(a) FY 2007 numbers have been adjusted to reflect FY 2008 presentation.
Certain direct costs have been moved to selling, general and
administrative to ensure consistency among all business segments.
PAREXEL International Corporation
Segment Information
($ in thousands)
Nine months ended
March 31,
2008 2007 (a)
Clinical Research Services (CRS)
Service revenue $533,606 $396,161
% of total service revenue
'/>"/>
| SOURCE PAREXEL International Corporation Copyright©2008 PR Newswire. All rights reserved |